|Articles|October 12, 2020
Patient Support Programs: Considerations for Crisis Management and Risk Mitigation
Author(s)Covance
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
When Drug Pricing Becomes Trade Policy
3
President Trump Set to Nominate Heidi Overton as FDA Commissioner
4
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
5